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ABSTRAK 
 
Melanin merupakan pigmen yang menentukan warna kulit. Sintesis melanin dimang-
kinkan oleh enzim tirosinase dan melibatkan pengawalaturan oleh gen TYR, TYRP1 
dan TYRP2. Dalam kajian ini, fraksi kaya tokotrienol (TRF) telah digunakan sebagai 
perencat sintesis melanin. TRF mengandungi 75% alfa-tokotrienol dan 25% tokoferol. 
Objektif kajian ini adalah untuk menentukan kesan fraksi kaya tokotrienol sawit terha-
dap sintesis melanin melalui penentuan kandungan aras melanin, aktiviti enzim tirosi-
nase dan ekspresi gen yang mengawalatur sintesis melanin di dalam melanosit kulit 
iaitu TYR, TYRP1 dan TYRP2. Sintesis melanin ditentukan melalui pengukuran kan-
dungan melanin dan asai aktiviti tirosinase. Ekspresi gen diukur dengan menggunakan 
kaedah kuantitatif PCR transkripsi berbalik (real time RT-PCR). Kultur primer sel mela-
nosit kulit dibahagikan kepada dua kumpulan iaitu kumpulan kawalan dan kumpulan 
perlakuan dengan TRF pada dos 500 µg/ml selama 24 jam. Hasil kajian menunjukkan 
terdapat penurunan kandungan melanin dan aktiviti tirosinase pada sel melanosit kulit 
yang diperlakukan dengan TRF berbanding sel kawalan (p<0.05). Ekspresi gen 
TYRP2 menunjukkan penurunan apabila melanosit diperlakukan dengan TRF ber-
banding dengan sel kawalan (p<0.05) . Oleh itu, dapat disimpulkan bahawa fraksi kaya 
tokotrienol sawit bertindak sebagai agen anti pigmentasi semasa penuaan kulit iaitu ia 
merencat sintesis melanin melalui perencatan aktiviti tirosinase dan menurunkan eks-
presi gen TYRP2. 
 
Kata kunci:  sintesis melanin, ekpresi gen, fraksi kaya tokotrienol, melanosit kulit 
 
 
ABSTRACT  
 
Melanin is the pigment that determines skin color. Melanin synthesis is catalysed by 
the enzyme tyrosinase and is controlled by TYR, TYRP1 and TYRP2 genes. In this 
study, tocotrienol rich fraction (TRF) was used to inhibit melanin synthesis. TRF 
contains 75% α-tocotrienol and 25% tocopherol. The objective of this study was to 
determine the effect of tocotrienol rich fraction (TRF) on melanin synthesis by 
determining melanin content and expression of genes involved in the regulation of 
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melanin synthesis in skin melanocytes. Melanin synthesis was studied by determining 
melanin level and tyrosinase enzyme activity, while expression of TYR, TYRP1 and 
TYRP2 genes was determined by quantitative real time reverse transcriptase poly-
merase chain reaction (real time RT-PCR). Primary culture of skin melanocytes were 
divided into two groups; control and cells that were treated with 500 µg/ml tocotrienol 
rich fraction for 24 hours. Our results showed that there was a reduction in melanin 
content and tyrosinase activity in skin melanocytes treated with tocotrienol rich fraction 
compared to the control (p<0.05). Expression of TYRP2 gene in melanocytes treated 
with tocotrienol rich fraction was also decreased (p<0.05) compared to the control. In 
conclusion, palm tocotrienol rich fraction has anti pigmentation property that inhibits 
melanin synthesis in cellular aging by inhibiting tyrosinase activity and down regulating 
TYRP2 gene expression. 
 
Key words:  melanin synthesis, gene expression, tocotrienol rich fraction, skin 
melanocytes 
 
 
 
INTRODUCTION  
 
Skin is the largest and outermost organ of 
the human body. The skin is frequently 
and directly exposed to a pro-oxidative 
environment, including ultraviolet radiation 
(UV), drugs, and air pollutants. Besides 
external inducers of oxidative attack, the 
skin has to cope with endogenous gen-
eration of reactive oxygen species (ROS) 
and other free radicals, which are con-
tinuously produced during physiological 
cellular metabolism.  
Balance between oxidants and antioxi-
dants is needed to minimize molecular, 
cellular, and tissue damage. However, if 
the balance is upset in favour of the oxi-
dants, oxidative stress could occur and 
results in oxidative damage. Reactive 
oxygen species (ROS) are known to 
cause oxidative modification of DNA, 
proteins, lipids and small cellular mole-
cules (Kang et al. 2005). To counteract 
the harmful effects of ROS, the various 
compartments of the skin (epidermis, 
dermis, subcutis) are equipped with lay-
erspecific antioxidant systems to maintain 
an equilibrium between ROS and antioxi-
dants and thus prevent oxidative stress 
(Thiele and Ekanayake-Mudiyanselage 
2007).  
Skin aging is defined as structural 
changes of skin as the age increase. Ag-
ing is indicated as inability to balance the 
important functions of skin leading to cell 
death. The free radical theory of aging 
explains the importance of antioxidants in 
reducing pigmentation in older people 
(Chandrosoma & Taylor 2001).  
The human pigmentary system is de-
pendent on the production of the light ab-
sorbing biopolymer, melanin, within epi-
dermal, ocular and follicular melanocytes 
(Nordlund et al. 1998). Melanocytes within 
the skin are situated on the basal layer 
between the dermis and epidermis and 
have a number of dendritic processes that 
interdigitate with the surrounding keratino-
cytes. While pigment synthesis occurs 
within the melanocytes, the majority of 
pigment within the skin is found in melanin 
laden vesicles known as melanosomes 
located within the keratinocytes (Sturm et 
al. 2001). 
Melanin synthesis is also known as 
melanogenesis where the pigment mela-
nin is formed. The melanin pigments are 
of no fixed molecular weight but are all 
derived by enzymatic oxidation of the 
amino acid tyrosine and eventually pro-
duce two types of melanin in mammalian 
skin which are feomelanin and eumelanin 
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(Prota 1992; Nordlund et al. 1998). Tyro-
sinases catalyze two distinct reactions in 
melanin synthesis: the hydroxylation of 
tyrosine to 3,4-dihydroxyphenylalanine 
(DOPA) and the oxidation of DOPA to 
dopaquinone (Tripathi et al. 1992). The 
eumelanins are derived from the metabo-
lites of DOPAchrome, whereas the pheo-
melanins are derived from metabolites of 
5-S-cysteinylDOPA. The isomerization of 
DOPAchrome to 5,6-dihydroxyindole-2-
carboxylic acid (DHICA) is catalysed by 
DOPAchrome tautomerase and the oxi-
dation of DHICA is performed by a DHICA-
oxidase enzyme (Sturm et al. 2001).  
Important genes involved in melanin 
synthesis pathway are TYR, TYRP1 and 
TYRP2. Tyrosinase is encoded by the TYR 
or c-locus that maps to chromosome 
11q14–21 in humans (Barton et al. 1988) 
and chromosome 7 in mice, respectively. It 
is composed of five exons and four introns 
(Jimbow et al. 2000). The gene for TYRP1 
is 37 kb long and contains eight exons 
separated by seven introns (Nordlund et al. 
1998). The gene for TYRP2 is 60 kb long 
and contains eight exons and seven 
introns; all eight exons encode the final 
protein (Budd and Jackson 1995). Gene 
and protein structures of tyrosinase, 
TYRP1 and TYRP2 consist of NH2- 
terminal domain of tyrosinase which 
comprises of the NH2-terminal signal 
peptide that is important for intracellular 
trafficking and processing, the EGF-
like/cysteine-rich domain, two histidine-rich 
regions binding copper with a cysteine-rich 
region between them (the important 
catalytic domain), as well as the COOH-
terminal hydrophobic transmembrane 
segment and cytoplasmic tail (Kwon 1993). 
The transmembrane and cytoplasmic 
domains are necessary for targeting the 
enzyme to the melanosome (Jimbow et al. 
2000; Selaturi 2000) while the NH2 
terminus cysteine-rich region may serve as 
a protein binding/regulatory domain 
unrelated to enzymatic function. 
Tocopherols and tocotrienols are sub-
families of vitamin E (Brigelius-Flohe & 
Traber 1999). Both tocopherols and to-
cotrienols have isomers, designated as -α, 
-β,-δ and -γ which differ by the number 
and position of the methyl groups on the 
chromanol ring (Machlin 1991). Tocotrie-
nol rich fractions are vitamin E that con-
sists of 75% alpha-tocotrienol and 25% 
tocopherol (Mutalib et al. 2003). Tocotrie-
nol rich fractions are found in barley, oats, 
palm, and commercial rice brans (Qureshi 
& Qureshi 1993). 
In this study, the anti pigmentation prop-
erties of palm tocotrienol rich fraction was 
evaluated. Primary culture of skin 
melanocytes was treated with tocotrienol 
rich fraction to evaluate the effects of 
tocotrienol rich fraction on melanin syn-
thesis by determining melanin content and 
tyrosinase enzyme activity. Determination 
of gene expression involved in the 
regulation of melanin synthesis such as 
TYR, TYRP1 and TYRP2 was also carried 
out. 
 
MATERIALS AND METHODS 
 
Cell culture 
 
Human melanocytes obtained from the 
foreskin of nine to 12 year-old boys were 
grown in Medium 254, which is a basal 
medium containing essential and non 
essential amino acids, vitamins, organic 
compounds, trace minerals, and inor-
ganic salts (Cascade Biologics, USA). 
The medium was supplemented with 
Human Melanocyte Growth Supplement-
2 (HMGS-2), which contains 0.5% fetal 
bovine serum, 3 ng/ml basic fibroblast 
growth factor (human recombinant), 0.2% 
bovine pituitary extract, 3 µg/ml heparin, 
0.18 µg/ml hydrocortisone, 5 µg/ml insu-
lin, 5 µg/ml transferrin, and 10 ng/ml 
phorbol 12- myristate 13-acetate. Written 
consent was obtained from parents or 
guardians of all subjects. 
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Cell viability assay 
 
Cell viability was assessed with CellTiter 
96* Aqueous Non-Radioactive Cell Pro-
liferation Assay (MTS, Promega, USA). 
The MTS assay employs 3-(4,5-dimethyl-
thiazol-2-yl)-5-carboxymethoxyphenyl) 2-
(4-sulfophenyl)-2H-tetrazolium (MTS) and 
the electron coupling agent phenazine 
methosulphate (PMS). The MTS com-
pound is reduced by the dehydrogenase 
enzymes found in metabolically active 
cells into a formazan product that is solu-
ble in the medium. The amount of colored 
formazan product is proportional to the 
number of viable cells. Briefly, 20 µl MTS 
solution was added to each well and incu-
bated in a humidified incubator at 370C in 
5% CO2 for 2 - 4 hours. The quantity of 
formazan product present was determined 
by measuring the absorbance at 490 nm 
with a microtiter plate reader (VeraMax 
Molecular Devices, USA). 
 
Determination of melanin content 
 
Melanin content was determined ac-
cording to Huang et al. (2008) with slight 
modification. The cells (105) were treated 
with 500µg/ml TRF (Sime Darby Bhd, 
Malaysia) for 24 hours. Cell pellets were 
dissolved in 1 ml of 1 N NaOH at 37 °C 
overnight and centrifuged for 10 minutes 
at 10,000 x g. The optical density (OD) of 
the supernatants was measured at 
450nm using the µQuant microplate 
reader. Melanin concentration was 
calculated by comparing the OD at 450 
nm of unknown samples with a standard 
curve (Figure 2).  
 
Determination of cellular tyrosinase 
activity 
 
Cellular tyrosinase activity was measured 
according to Lin et al. (2007), with slight 
modification. Melanocytes (105) were 
cultured in 24-well plates for 24 hours 
followed by 24 hours treatment with 
500µg/ml TRF (Sime Darby Bhd, Malay-
sia). Cells were then washed and lysed 
with potassium phosphate-buffered sa-
line (PBS) pH 6.8 containing 1% Triton X-
100 and ruptured by freezing at -80°C 
and thawing in a water bath. Cell lysates 
were then clarified by centrifugation at 
10,000 x g for 10 minutes. Protein con-
tent was determined using Bradford as-
say. Protein concentrations were ad-
justed with lysis buffer until each lysate 
contained the same amount of protein 
(40 µg). The final reaction mixture in 
each well contained the cell lysate, 10 µl 
2.5 mM L-dopa, and 0.1 M PBS pH 6.8. 
Absorbance was then measured at 475 
nm using the µQuant microplate reader 
after incubation at 37°C for 1 hour. 
 
RNA extraction 
 
Total RNA from fibroblast cells in different 
groups were extracted using TRI Reagent 
(Molecular Research Centre, Cincinnati 
OH) according to the manufacturer’s 
instruction. Polyacryl Carrier was added in 
each extraction to precipitate the total RNA. 
Extracted RNA pellet was then washed 
with 75% ethanol and dried before being 
dissolved in RNase and DNase free 
distilled water (Gibco Invitrogen Corp.). 
Total RNA was stored at -80°C 
immediately after extraction. Yield and 
purity of the extracted RNA was de-
termined by Nanodrop (Thermo Scientific). 
 
Primer design 
 
Primers for human GADPH and gene of 
interest were designed with Primer 3 
software and blasted with Genebank da-
tabase sequences. The sequence of the 
primers is shown in Table 1. 
 
Real time RT-PCR 
 
Gene expression of TYR, TYRP1, 
TYRP2 was quantitatively analysed with 
real time RT-PCR technique. The ex-
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Table 1 : Primer sequences for quantitative gene expression analysis 
 
Gene Accession numbers Primer sequence (5’?3’) PCR product 
size (bp) 
GAPDH BC020308 F: tcc ctg agc tga acg gga ag 
R: gga gga gtg ggt gtc gct gt 
217 
TYR 
 
NM_000372.3 F: gatgagtacatgggaggtcagc 
R: gtactcctccaatcggctacag 
102 
 
TYRP1 
 
NM_000550.1  
 
F: gctccagacaacctgggata 
R: tcagtgaggagaggctggtt 
185 
 
TYRP2 NM_001922.2 F: agattgcctgtctctccagaag 
R: cttgagaatccagagtcccatc 
116 
 
pression level of each targeted gene was 
normalized to GAPDH. Primers for hu-
man GAPDH, TYR, TYRP1, TYRP2 were 
designed with Primer 3 software and 
blasted with GeneBank database se-
quences in order to obtain primers with 
high specificity. The efficiency and speci-
ficity of each primer set were confirmed 
with standard curve (Ct value versus se-
rial dilution of total RNA) and melting 
profile evaluation. Real time RT-PCR re-
action was performed with 100 ng of total 
RNA, 400 nM of each primer and iScript 
One-Step RT-PCR kit with SYBR Green 
(Biorad) according to the manufacturer’s 
instruction. Reactions were run using 
Bio-Rad iCycler with reaction profile as 
follows; cDNA synthesis for 30 min at 
50°C; pre-denaturation for 2 min at 94°C; 
PCR amplification for 38 cycles with 30 
sec at 94°C, 30 sec at 60°C and 30 sec 
at 72°C. This was followed by a melt 
curve analysis to determine the reaction 
specificity. Agarose gel electrophoresis 
was performed for confirmation of the 
PCR product. Expression level of each 
targeted gene was normalized to 
GAPDH. 
 
Statistical analysis 
 
Each experiment was carried out in tripli-
cates with at least 3 independent cultures 
with comparable results. Data are re-
ported as mean + SD of at least three 
experiments. Comparison between 
groups was made by Student’s t-test 
(two-tailed). P<0.05 was considered sta-
tistically significant. 
 
RESULTS 
 
Effects of Tocotrienol Rich Fraction on 
cell viability 
 
Incubation of melanocytes with different 
concentrations of tocotrienol rich fraction 
(100, 200, 300, 400, 500 ug/ml) for 24 
hours caused an increase in the number 
of viable cells (Figure 1). The percentage 
of the viable cells was increased with in-
creased concentration of tocotrienol rich 
fraction. Tocotrienol rich fraction at 500 
ug/ml was used in this study to determine 
its effects on melanin synthesis. 
 
Effects of Tocotrienol Rich Fraction on 
melanin content and tyrosinase activity.  
 
Melanin concentration was calculated by 
comparing the OD at 450 nm of unknown 
samples with a standard curve (Figure 2). 
Results showed that treatment with toco-
trienol rich fraction caused a significant 
reduction in melanin content (Figure 3) 
(p<0.05) as compared to the untreated 
control. Tyrosinase activity was signifi- 
cantly lower (p<0.05) in melanocytes 
treated with tocotrienol rich fraction (Fig-
ure 4) compared to the untreated control. 
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Figure 1:  Effects of palm tocotrienol rich fraction 
(TRF) on melanocyte proliferation as assessed by 
MTS assay. Percent MTS reduction corresponds to 
the viable cell number. Melanocytes were incubated 
with increasing concentrations of TRF for 24 hours 
at 37oC. Incubation with TRF caused a significant 
increase in the number of cell viable. * Denotes 
p<0.05 compared to untreated control, # p<0.05 
compared to previous concentration. Data is 
presented as means + SD, n = 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Standard curve for synthetic melanin 
 
 
Effects of tocotrienol rich fraction on the 
expression of TYR, TYRP1 and TYRP2 
genes 
 
The agarose gel electrophoresis showed 
a single band of PCR product indicating 
that the primers were specific (Figure 
5a). The melting curve analysis showed 
single and narrow peak as an indication 
of primer specificity (Figure 5b-e) 
Results showed that treatment with to-
cotrienol rich fraction caused a significant 
downregulation of TYRP2 gene (p<0.05) 
compared to the untreated control (Fig-
ure 6). Expression of TYR and TYRP1 
genes was not significant from the un-
treated control. 
 
DISCUSSION 
 
Previous study reported that compounds 
with redox properties or (antioxidants) 
may have anti pigmentation effects by 
interacting with o-quinones or interacting 
with copper at the tyrosinase active site, 
thus avoiding the oxidative polymeriza-
tion of melanin intermediates. Redox 
agents could inhibit second messengers 
which were able to stimulate epidermal 
melanogenesis either directly or indirectly 
by scavenging reactive oxygen species 
generated in the skin following UV expo-
sure (Karg et al. 1993). Our findings 
showed that melanin content and tyrosi-
nase activity were significantly reduced in 
melanocytes treated with 500 µg/ml to-
cotrienol rich fraction. 
It has been reported that α-tocopherol 
derivatives could inhibit tyrosinase in vitro 
(Shimizu et al. 2001) and inhibit melano-
genesis in epidermal melanocytes 
(Ichihashi et al. 1999). The antioxidant 
properties of α-tocopherol (25% in to-
cotrienol rich fraction), which interfere 
lipid peroxidation of melanocyte mem-
branes and increased intracellular glu-
tathione content, could explain its depig-
menting effect (Marmol et al. 1993). 
Other antioxidants such as ascorbic acid 
interfere with the different steps of 
melanization by interacting with copper 
ion at the tyrosinase active site 
(Gukasyan 2002) or/and reducing 
dopaquinone as well as blocking DHICA 
oxidation (Ros et al. 1993) thus causing 
reduction in pigmentation.  
Tyrosinase activity was an important and 
significant parameter to measure 
melanogenesis in pigment cell culture (Hu  
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Figure 3:  Anti pigmentation effects of palm 
tocotrienol rich fraction (TRF) as shown by 
reduction in melanin content (ng/cell) in TRF-
treated skin melanocytes. Primary culture of skin 
melanocytes was treated with 500 ug/ml TRF for 24 
hours at 37oC. *Denotes p<0.05 compared to 
untreated control. Data is presented as mean ± SD, 
n=3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4:  Anti pigmentation effects of palm 
tocotrienol rich fraction (TRF) as shown by 
reduction in tyrosinase activity (U/ug protein) in 
TRF-treated skin melanocytes. Primary culture of 
skin melanocytes was treated with 500 ug/ml TRF 
for 24 hours at 37oC. * Denotes p<0.05 compared to 
untreated control. Data is presented as mean ± SD, 
n=3. 
 
2008). The significant reduction in 
tyrosinase activity and melanin content in 
the tocotrienol rich fraction-treated melano-
cytes in this study showed inhibition of 
melanogenesis in these cells. Similar 
findings were reported in previous studies 
that used active constituents from 
formosan apple (Lin et al. 2007), 
aloesin (Jones et al. 2002), picnogenol 
(Kim et al. 2008) and anemonin (Huang 
et al. 2008). 
Melanin synthesis was affected by 
many factors such as the presence of 
TRP-1 and TRP-2 proteins, UV expo-
sure, prostaglandin, vitamins, growth 
factors, interleukin, interferon and hor-
mones such as alpha-melanocyte stimu-
lating hormone, adrenocortropic hormone 
and endothelin-1 (Fang et al. 2002). Ge-
netic control was also involved in melanin 
synthesis (Rinchik et al. 1993). 
Our results showed that TYRP2 gene 
expression was significantly reduced in 
tocotrienol rich fraction-treated melano-
cytes while TYR and TYRP1 genes de-
creased insignificantly. These findings 
showed TYRP2 expression was affected 
by tocotrienol rich fraction treatment but 
not for TYR and TYRP1 genes expres-
sion. A previous study reported that anti-
oxidants caused reduction in tyrosinase 
activity but did not affect the tyrosinase 
related protein itself (Khatib et al. 2005; 
Kim et al. 2006).  
Huang et al. (2008) reported that 
anemonin, a natural bioactive compound, 
could regulate tyrosinase-related proteins 
and mRNA in human melanocytes. 
Eberle et al. (2001) showed that catechol 
could inhibit gene expression encoded 
for TRP-2 protein which was TYRP2. 
TYR is controlled by a quantitative 
rheostat-like switch which allows con-
tinuous transcription of TYR meanwhile 
TYRP1 is controlled by binary switch that 
would allow transcription of genes only at 
certain time. Therefore TYR has variable 
control mechanisms such as regulation at 
transcription level, and post translational 
mechanism as well as affected by mRNA 
stability (Hazily et al. 2002). 
TYR, TYRP1 and TYRP genes have 
been cloned and extrinsic factors regu-
lating their expression were recently 
identified. It was reported that TYRP1 
and TYRP2 genes may act together to 
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Figure 5: Agarose gel electrophoresis for TYR, TYRP1, TYRP2 primers in human skin melanocytes. Primers 
were specific to gene of interest (a). Specificity of primer was shown by melting curve graph. Single and 
narrow peak indicated primers were specific for GAPDH gene (b), TYR gene (c), TYRP1 gene and TYRP2 
gene (e). 
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Figure 6: Effects of palm tocotrienol rich fraction 
(TRF) on TYR, TYRP1, TYRP2 mRNA expression 
in TRF-treated skin melanocytes. Primary culture of 
skin melanocytes was treated with 500 ug/ml TRF 
for 24 hours at 37oC. * Denotes p<0.05 compared to 
untreated control. Data is presented as mean ± SD, 
n=2. 
 
modulate TYR activity (Manga et al. 
2000). This may explained the down 
regulation of TYRP2 gene in this study 
that affect the activity of tyrosinase en-
zyme. 
 
CONCLUSION 
 
In conclusion, the significant reduction in 
tyrosinase activity and melanin content in 
melanocytes treated with tocotrienol rich 
fraction and down regulation of TYRP2 
gene confirmed the anti pigmentation 
property of palm tocotrienol rich fraction, 
an invaluable finding in the cosmetic in-
dustry. 
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